XML 15 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 6,161 $ 4,880
Fixed Maturities, Current 26,219 26,267
Equity securities 1,662 1,881
Premium receivables 7,349 5,681
Self-funded receivables 3,979 4,010
Other receivables 3,334 3,749
Other current assets 5,193 4,654
Total current assets 53,897 51,122
Long-term investments:    
Fixed maturities, Long-term 596 632
Other invested assets 5,365 5,225
Property and equipment, net 3,986 3,919
Goodwill 24,251 24,228
Other intangible assets 10,588 10,615
Other noncurrent assets 1,803 1,719
Total assets 100,486 97,460
Current Liabilities:    
Medical claims payable 14,713 13,518
Other policyholder liabilities 5,396 5,521
Unearned income 1,210 1,153
Accounts payable and accrued expenses 5,493 4,970
Short-term borrowings 275 275
Current portion of long-term debt 3,097 1,599
Other current liabilities 9,549 7,849
Total current liabilities 39,733 34,885
Long-term debt, less current portion 19,883 21,157
Reserves for future policy benefits, noncurrent 811 802
Deferred tax liabilities, net 2,349 2,805
Other noncurrent liabilities 1,679 1,683
Total liabilities 64,455 61,332
Commitments and contingencies – Note 11
Shareholders' equity    
Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none 0 0
Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding – 241,140,929 and 241,770,746 2 2
Additional paid-in capital 9,151 9,148
Retained earnings 28,058 27,088
Accumulated other comprehensive loss (1,236) (178)
Total shareholders' equity 35,975 36,060
Noncontrolling interests 56 68
Total equity 36,031 36,128
Total liabilities and shareholders' equity $ 100,486 $ 97,460